Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population analysis of pharmacogenetic polymorphisms related to acute lymphoblastic leukemia drug treatment.

Disease markers - 1 Jan 2012

Chiabai Marcela A, Lins Tulio C L, Pogue Robert, Pereira Rinaldo W

Abstract excerpt

This study aimed to evaluate in the Brazilian population, the genotypes and population frequencies of pharmacogenetic polymorphisms involved in the response to drugs used in treatment of acute lymphoblastic leukemia (ALL), and to compare the data with data from the HapMap populations. There was significant differentiation between most population pairs, but few associations between genetic ancestry and SNPs in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Biotransformation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucocorticoids

Share to HapMap Project

Share to Mercaptopurine

Share to Methotrexate

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Racial Groups

Source

Open in PubMed Open full text

Identifiers

PMID: 22430191
DOI: 10.3233/DMA-2011-0884
PMCID: PMC3826589

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population analysis of pharmacogenetic polymorphisms related to acute lymphoblastic leukemia drug treatment.PMID 22430191Read ↗

Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Pharmacogenomic implications of population admixture: Brazil as a model case.Semantic proximity Read ↗

Population Diversity in Pharmacogenetics: A Latin American Perspective.Semantic proximity Read ↗

Genetic basis of clinical variants of chemotherapy toxicity in children with acute lymphoblastic leukemia (literature review)Semantic proximity Read ↗

Genetic structure of pharmacogenetic biomarkers in Brazil inferred from a systematic review and population-based cohorts: a RIBEF/EPIGEN-Brazil initiative.Semantic proximity Read ↗

Pharmacogenetic studies in children with acute lymphoblastic leukemia in Argentina.Semantic proximity Read ↗

On the use of pharmacogenetics in cancer treatment and clinical trials.Semantic proximity Read ↗

Establishment of a biobank and pharmacogenetics database of African populationsSemantic proximity Read ↗

Allele frequencies of pharmacogenetic biomarkers and genomic ancestry in a sample of the Cuban population.Semantic proximity Read ↗

Pharmacogenetic Variation and Its Clinical Relevance in a Latin American Rural Population.Semantic proximity Read ↗

Application of the F(ST) statistics to explore pharmacogenomic diversity in the Brazilian population.Semantic proximity Read ↗

[Genetic polymorphism and outcome in acute lymphoblastic leukaemia of childhood].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.